Regeneron Pharmaceuticals, Inc. (VIE:REGN)
Austria · Delayed Price · Currency is EUR 689.80
-9.40 (-1.34%)
At close: Jan 9, 2026
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of €66.39 billion as of January 15, 2026. Its market cap has decreased by -10.32% in one year.
Market Cap
66.39B
Enterprise Value
52.64B
Revenue
12.14B
Ranking
n/a
PE Ratio
17.02
Stock Price
€689.80
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 131.41M to 66.39B, an increase of 50,424.72%. That is a compound annual growth rate of 20.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 66.91B | -0.80% |
| Dec 31, 2025 | 67.45B | -8.88% |
| Dec 31, 2024 | 74.03B | -12.40% |
| Dec 29, 2023 | 84.50B | 17.20% |
| Dec 30, 2022 | 72.10B | 24.19% |
| Dec 31, 2021 | 58.06B | 39.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Erste Group Bank AG | 40.78B |
| VERBUND AG | 21.70B |
| OMV Aktiengesellschaft | 16.14B |
| Raiffeisen Bank International AG | 12.07B |
| BAWAG Group AG | 10.01B |
| Strabag SE | 9.54B |
| Vienna Insurance Group AG | 8.33B |
| Voestalpine AG | 6.85B |